Comparison Snapshot: Tirzepatide versus Semaglutide Clinical trials show both medications are effective for weight reduction, but tirzepatides dual GIP and GLP-1 activity produced larger average weight loss than semaglutide in head-to-head studies
When a pharmacys entire identity is compounding, quality is not a department it is the institution
Weight loss itself is a significant contributor to improved mental health outcomes
Ever since blockbuster weight-loss drugs like Wegovy and Zepbound went mainstream, calls to local poison control centers about side effects, incorrect dosing and other types of exposure are on a steep rise
We saw similar concerns previously with stimulant prescribing during the expansion of telehealth platforms
Notably, similar synergy occurred with exenatide (PT302 long-acting, 1 mg/kg weekly) plus Vutiglabridin (30 mg/kg) over 4 weeks